Cerebral Amyloid Angiopathy

This article by Steven M. Greenberg examines cerebral amyloid angiopathy (CAA), a significant cause of hemorrhagic stroke and cognitive decline, and seeks to address the challenges in diagnosing and managing the condition. The authors highlight the need for improved risk prediction tools, early diagnostic markers, and potential therapeutic targets to better manage the high risk of recurrent strokes associated with CAA. Ongoing research aims to enhance understanding of the disease's pathology and inform treatment strategies.